Extensive prior studies have suggested a critical role of tumor-intrinsic factors in mediating differential responses to ICI, including tumor mutational burden (TMB), PD-L1 expression, or genetic and epigenetic differences in tumor cells themselves (Figure 1). Here, CD274 is linked to neoplasm.